Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 118 member B (FAM118B) is a protein-coding gene encoding a 34-kDa protein that primarily localizes in the nucleus, concentrating in Cajal bodies—a type of subnuclear structure involved in the biogenesis of small nuclear ribonucleoproteins (snRNPs) essential for pre-mRNA splicing[1][2][3]. FAM118B interacts with core Cajal body components such as coilin and the SMN complex and is necessary for proper Cajal body assembly, splicing factor modification, and efficient pre-mRNA splicing[2]. Depletion of FAM118B disrupts Cajal body morphology, reduces splicing efficiency, and lowers cell proliferation, underscoring its importance in cell viability and nuclear RNA metabolism[2][3]. Although associated with certain cancer types, FAM118B is not currently characterized as a classical therapeutic target, such as a druggable enzyme or receptor[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 118 member B (FAM118B).